clinical trial · NCT03532542
An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Duchenne Muscular DystrophyCasimersenGolodirsen
brief summary
The main objective of this study is to evaluate the safety and tolerability of long-term treatment with casimersen or golodirsen in patients with Duchenne muscular dystrophy (DMD).
started
Aug 2, 2018
primary completion
Jul 26, 2023
completion
Jul 26, 2023
last updated
Sep 19, 2024
official title
Long-term, Open-label Extension Study for Patients With Duchenne Muscular Dystrophy Enrolled in Clinical Trials Evaluating Casimersen or Golodirsen
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol